Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Rheumatic Heart DiseaseCoronary Heart Disease
Interventions
DRUG

Glutamine

20% N(2)-L-alanyl-L-glutamine 0.4g/kg(2ml/kg) mixed with compound amino acid (10ml/kg).Intravenous injection twice (24 hours、1 hour before operation). Injection rate = 6ml/kg/h

DRUG

Ringer's solution

Ringer's solution 12ml/kg. Intravenous injection twice (24 hours、1 hour before operation). Injection rate = 6ml/kg/h.

Trial Locations (1)

210009

Zhongda Hospital Southeast University, Nanjing

All Listed Sponsors
lead

Yuejiang Liu

OTHER

NCT01794884 - Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery | Biotech Hunter | Biotech Hunter